Journal of Molecular Biology
Diffusion of univalent ions across the lamellae of swollen phospholipids
The diffusion of univalent cations and anions out of spontaneously formed liquid crystals of lecithin is remarkably similar to the diffusion of such ions across biological membranes. If the unit structure of the liquid crystal is accepted as being that of a bimolecular leaflet, then these leaflets have been shown to be many orders of magnitude more permeable to anions than to cations. The diffusion rate for cations is very significantly controlled by the sign and magnitude of the surface charge at the water/lipid interface. There is a decrease of the diffusion rate for cations as the negative charge on the lipid structure decreases—which diminishes to zero for a positively charged membrane—the diffusion rate of anions remaining very high. The exchange diffusion rate of Cl− and I− was greater than that of F−, NO3−, SO42− and HPO42− but no significant differences were detectable for the cation series, Li+, Na+, K+, Rb+ and choline. The membranes are very permeable to water.
Because the diffusion rate of cations is low, the phospholipid liquid crystalline structures appear to “bind” or “capture” cations. It is found that as the surface charge of the lipid lamellae is increased, the amount of cation per μmle of lipid increases. It is argued that if the cation is sequestered in aqueous compartments between the bimolecular leaflets, and if the thickness of the aqueous compartments is determined by the surface charge density of the lipid head groups and by the ionic strength of the aqueous phase in accordance with double-layer theory, the amount of cation trapped would also be expected to vary.
References (29)
- A.D. Bangham et al.
J. Mol. Biol.
(1964) - A.D. Bangham et al.
J. Mol. Biol.
(1965) - I.M. Glynn
Progr. Biophys. Biophys. Chem.
(1957) - D.A. Haydon et al.
J. Theoret. Biol.
(1963) - C. Huang et al.
J. Mol. Biol.
(1964) - J.A. Lucy
J. Theoret. Biol.
(1964) - D. Papahadjopoulos et al.
Biochim. biophys. Acta
(1964) - P.J. Anderson et al.
- A.D. Bangham
- A.D. Bangham et al.
Nature
(1958)
Biochem. J.
Proc. Nat. Acad. Sci., Wash.
Cited by (3811)
Liposomic nano particles in the treatment of colorectal and ovarian cancer
2024, European Journal of Medicinal Chemistry ReportsCancer is an expansionist disease, it invades through tissues, sets up colonies in hostile landscapes, seeking “sanctuary” in one organ and then immigrating to another. Ovarian and colorectal cancer has high mortality rates in India. Colorectal cancer typically begins in the gut lining and can spread through the colon wall and beneath the muscular layers, and is a significant source of morbidity. Ovarian cancer has the highest recurrence rate of all gynaecologic cancers and has high mortality because of late diagnosis brought on by vague symptoms. In this review article, we have discussed that apart from the conventional ways of treatment, how nanoparticles has the potential to improve the detection, diagnosis, and treatment of these cancers. Liposomal nanoparticles are lipid-based vesicles that can encapsulate drugs and deliver them to specific targets in the body, potentially improving the effectiveness and reducing the side effects of the treatment. This article also provides an insight on the fact that while liposomal nanoparticles show promising effect, there are challenges to be addressed, including optimizing drug release rates, and ensuring effective targeting.
Pegylated liposome encapsulating docetaxel using microfluidic mixing technique: Process optimization and results in breast cancer models
2024, International Journal of PharmaceuticsThe development of nanoparticles could help to improve the efficacy/toxicity balance of drugs. This project aimed to develop liposomes and immunoliposomes using microfluidic mixing technology.Various formulation tests were carried out to obtain liposomes that met the established specifications. The liposomes were then characterized in terms of size, polydispersity index (PDI), docetaxel encapsulation rate and lamellarity. Antiproliferative activity was tested in human breast cancer models ranging from near-negative (MDA-MB-231), positive (MDA-MB-453) to HER2 positive. Pharmacokinetic studies were performed in C57BL/6 mice.Numerous batches of liposomes were synthesised using identical molar ratios and by varying the microfluidic parameters TFR, FRR and buffer. All synthesized liposomes have a size < 200 nm, but only Lipo-1, Lipo-6, Lipo-7, Lipo-8 have a PDI < 0.2, which meets our initial requirements. The size of the liposomes was correlated with the total FRR, for a 1:1 FRR the size is 122.2 ± 12.3 nm, whereas for a 1:3 FRR the size obtained is 163.4 ± 34.0 nm (p = 0.019. Three batches of liposomes were obtained with high docetaxel encapsulation rates > 80 %. Furthermore, in vitro studies on breast cancer cell lines demonstrated the efficacy of liposomes obtained by microfluidic mixing technique. These liposomes also showed improved pharmacokinetics compared to free docetaxel, with a longer half-life and higher AUC (3-fold and 3.5-fold increase for the immunoliposome, respectively).This suggests that switching to the microfluidic process will produce batches of liposomes with the same characteristics in terms of in vitro properties and efficacy, as well as the ability to release the encapsulated drug over time in vivo. This time-efficiency of the microfluidic technique is critical, especially in the early stages of development.
Comparative analysis of whole cell-derived vesicular delivery systems for photodynamic therapy of extrahepatic cholangiocarcinoma
2024, Journal of Photochemistry and Photobiology B: BiologyThis first-in-its-class proof-of-concept study explored the use of bionanovesicles for the delivery of photosensitizer into cultured cholangiocarcinoma cells and subsequent treatment by photodynamic therapy (PDT). Two types of bionanovesicles were prepared: cellular vesicles (CVs) were fabricated by sonication-mediated nanosizing of cholangiocarcinoma (TFK-1) cells, whereas cell membrane vesicles (CMVs) were produced by TFK-1 cell and organelle membrane isolation and subsequent nanovesicularization by sonication. The bionanovesicles were loaded with zinc phthalocyanine (ZnPC). The CVs and CMVs were characterized (size, polydispersity index, zeta potential, stability, ZnPC encapsulation efficiency, spectral properties) and assayed for tumor (TFK-1) cell association and uptake (flow cytometry, confocal microscopy), intracellular ZnPC distribution (confocal microscopy), dark toxicity (MTS assay), and PDT efficacy (MTS assay). The mean ± SD diameter, polydispersity index, and zeta potential were 134 ± 1 nm, −16.1 ± 0.9, and 0.220 ± 0.013, respectively, for CVs and 172 ± 3 nm, −16.4 ± 1.1, and 0.167 ± 0.022, respectively, for CMVs. Cold storage for 1 wk and incorporation of ZnPC increased bionanovesicular diameter slightly but size remained within the recommended range for in vivo application (136–220 nm). ZnPC was incorporated into CVs and CMVs at an optimal photosensitizer:lipid molar ratio of 0.006 and 0.01, respectively. Both bionanovesicles were avidly taken up by TFK-1 cells, resulting in homogenous intracellular ZnPC dispersion. Photosensitization of TFK-1 cells did not cause dark toxicity, while illumination at 671 nm (35.3 J/cm2) produced LC50 values of 1.11 μM (CVs) and 0.51 μM (CMVs) at 24 h post-PDT, which is superior to most LC50 values generated in tumor cells photosensitized with liposomal ZnPC. In conclusion, CVs and CMVs constitute a potent photosensitizer platform with no inherent cytotoxicity and high PDT efficacy in vitro.
Trastuzumab-conjugated liposomes for co-delivery of paclitaxel and anti-abcb1 siRNA in HER2-positive breast cancer: In vitro and in vivo evaluations
2024, Journal of Drug Delivery Science and TechnologyChemotherapeutic drugs often face challenges such as non-specific binding, undesired toxicity, and limited blood circulation, leading to reduced therapeutic efficacy. This study introduces HER2-specific targeted nanoparticles designed by synthesizing cationic liposomes. These liposomes encapsulate paclitaxel and ABCB1-siRNA in their core and feature a therapeutic monoclonal antibody, trastuzumab, on the surface. This design aims for precise targeting and synergistic treatment of HER2-positive breast cancer cells in both in vitro and in vivo models. The optimized trastuzumab-conjugated liposomes exhibited a particle size of 229 ± 4 nm and a zeta potential of 43.46 ± 0.61 mV. Their spherical morphology was confirmed using Scanning Electron Microscopy (SEM). These liposomes demonstrated enhanced drug retention in in vitro release studies. Furthermore, trastuzumab-conjugated liposomes displayed markedly higher cellular uptake than their non-trastuzumab-conjugated counterparts. Their anticancer efficacy in BT-474 cells significantly surpassed that of non-targeted liposomes and unencapsulated paclitaxel. In xenograft Nude mice models derived from the BT-474 cell line, trastuzumab-conjugated liposomes showed superior tumor distribution and preclinical effectiveness compared to both non-targeted liposomes and plain paclitaxel.
Engineering aspects of lipid-based delivery systems: In vivo gene delivery, safety criteria, and translation strategies
2024, Biotechnology AdvancesDefects in the genome cause genetic diseases and can be treated with gene therapy. Due to the limitations encountered in gene delivery, lipid-based supramolecular colloidal materials have emerged as promising gene carrier systems. In their non-functionalized form, lipid nanoparticles often demonstrate lower transgene expression efficiency, leading to suboptimal therapeutic outcomes, specifically through reduced percentages of cells expressing the transgene. Due to chemically active substituents, the engineering of delivery systems for genetic drugs with specific chemical ligands steps forward as an innovative strategy to tackle the drawbacks and enhance their therapeutic efficacy. Despite intense investigations into functionalization strategies, the clinical outcome of such therapies still needs to be improved. Here, we highlight and comprehensively review engineering aspects for functionalizing lipid-based delivery systems and their therapeutic efficacy for developing novel genetic cargoes to provide a full snapshot of the translation from the bench to the clinics. We outline existing challenges in the delivery and internalization processes and narrate recent advances in the functionalization of lipid-based delivery systems for nucleic acids to enhance their therapeutic efficacy and safety. Moreover, we address clinical trials using these vectors to expand their clinical use and principal safety concerns.
Dynamics of giant vesicle assembly from thin lipid films
2024, Journal of Colloid and Interface ScienceGiant unilamellar vesicles (GUVs), cell-like synthetic micrometer size structures, assemble when thin lipid films are hydrated in aqueous solutions. Quantitative measurements of static yields and distribution of sizes of GUVs obtained from thin film hydration methods were recently reported. Dynamic data such as the time evolution of yields and distribution of sizes, however, is not known. Dynamic data can provide insights into the assembly pathway of GUVs and guidelines for choosing conditions to obtain populations with desired size distributions.
We develop the ‘stopped-time’ technique to characterize the time evolution of the distribution of sizes and molar yields of populations of free-floating GUVs. We additionally capture high resolution time-lapse images of surface-attached GUV buds on the lipid films. We systematically study the dynamics of assembly of GUVs from three widely used thin film hydration methods, PAPYRUS (Paper-Abetted amPhiphile hYdRation in aqUeous Solutions), gentle hydration, and electroformation.
We find that the molar yield versus time curves of GUVs demonstrate a characteristic sigmoidal shape, with an initial yield, a transient, and then a steady state plateau for all three methods. The population of GUVs showed a right-skewed distribution of diameters. The variance of the distributions increased with time. The systems reached steady state within 120 min. We rationalize the dynamics using the thermodynamically motivated budding and merging (BNM) model. These results further the understanding of lipid dynamics and provide for the first-time practical parameters to tailor the production of GUVs of specific sizes for applications.
- 1
One of us (M. M. S.) was a visiting scientist from Unilever, Colworth House, Bedford, and another (J. C. W.) was a visiting scientist from the Department of Physiology, Australian National University, Canberra, Australia.